Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions

Hana Vaknin-Assa, Abid Assali, Ran Kornowski*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The MGuard stent has been designed as a plaque trapping device to treat atherothrombotic lesions in saphenous vein grafts and native coronary lesions. It was utilized in seven coronary bypass patients to treat eight vein grafts. The average graft age was 15 years. Procedural success was 100% without any intraprocedural, in-hospital, and/or 30-day major adverse cardiac events (e.g. death, myocardial infarction, and need for repeat graft revascularization). No patient experienced distal embolization and/or procedure-related CK enzymatic rise. This strategy seems to be a promising approach in percutaneous vascular management of vein graft lesions.

Original languageEnglish
Pages (from-to)1055-1057
Number of pages3
JournalCatheterization and Cardiovascular Interventions
Volume74
Issue number7
DOIs
StatePublished - 1 Dec 2009

Keywords

  • Acute coronary syndrome
  • Bypass grafts
  • Coronary
  • Embolization
  • Percutaneous coronary intervention
  • Thrombosis

Fingerprint

Dive into the research topics of 'Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions'. Together they form a unique fingerprint.

Cite this